Priay Kishnani, M.D., Chief of the Division of Medical Genetics, Department of Pediatrics and Director of the YT and Alice Chen Center for Genomic Research at Duke Health, will open the CED Life Science Conference February 27. The CED also set its agenda for the event.

Pre-conference sessions from 9 a.m. to 10 a.m. features eight of the most promising life science startups from Duke, North Carolina State University, Wake Forest, and the University of North Carolina at Chapel Hill. The startups are: 410 Medical, Agile Sciences, AnelleO, EncepHeal Therapeutics, Phitonex, Spyryx, Zephyr Mobility, and Chondrial Therapeutics Inc.

An Investors reverse pitch lunch open only to registered entrepreneurs and investors follows at 11 am.

The conference officially opens at 1 p.m.  with Kishnani followed by lighting round company presentations by diagnostics and medical device firms.

Other highlights include investor panels, a healthcare provider pane, and the CED Showcase Alumni company updates from AgBiome, Baebies, G1 Therpeutics, Locus Biosciences, and Precision Biosciences.

Biotech and pharmaceutical lightening round company presentations follow on day two with another stellar investor panel.

Max Wallace, CEO of Accelerate Brain Cancer Cure and well known in the Triangle for his role at Trimeris and as an entrepreneur, will receive the CED Life Science Leadership Award following lunch.

Gary Glick, president and CEO of IFM therapeutics presents the Serial VC-backed biotech entrepreneur talk.

More than 70 companies are featured during the two-day event.